Last reviewed · How we verify
NCT03709992
Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:
NA trial testing Trospium Chloride in Ureter Stone in 200 participants. Suspended.
1 August 2024
Quick facts
| Lead sponsor | Mansoura University |
|---|---|
| Phase | NA |
| Status | Suspended |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 18 December 2020 |
| Primary completion | 1 August 2024 |
| Estimated completion | 1 November 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Trospium Chloride — full drug profile →
- Tamsulosin (tamsulosin) — full drug profile →
Conditions studied
- Ureter Stone — all drugs for Ureter Stone →
- Quality of Life — all drugs for Quality of Life →
- Ureter Obstruction — all drugs for Ureter Obstruction →
Sponsor
Mansoura University
Who can join
21 and older, any sex, with Ureter Stone or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will be conducted to compare the efficacy and safety of Trospium chloride versus Tamsulosin for treatment of ureteral stent related symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03709992
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Trospium Chloride
Trials testing the same drug.
- NCT07063342 — A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to · Phase 1 · recruiting
Other recruiting trials for Ureter Stone
Currently open trials in the same condition.
- NCT06412900 — Radiomics and Image Segmentation of Urinary Stones by Artificial Intelligence · active not recruiting
Other Mansoura University trials
Trials by the same sponsor.
- NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
- NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
- NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
- NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
- NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03709992 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mansoura University
- Last refreshed: 12 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03709992.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing